CID2136

“Treatment of pediatric growth hormone deficiency (pGHD) involves daily injections of somatropin, a recombinant human growth hormone (r-hGH), administered subcutaneously,” explained the authors of a study published in Current...

Researchers have identified a wide spectrum of growth disorders—including several not previously considered part of the growth hormone insensitivity (GHI) spectrum—presenting analogously with short stature and normal GH...

Children with isolated growth hormone deficiency (IGHD) with isolated pituitary hypoplasia (IPH) had lower free thyroxine (FT4) levels than children with IGHD without pituitary abnormalities, according to a study published in...

Discrepancies between the laboratory testing and molecular diagnosis of GHD should be considered when seeking an accurate diagnosis of GHD, according to a study published in Frontiers in Endocrinology. To screen disease-causing...

To avoid missing a tumor, the importance of administering MRI in children with pediatric growth hormone deficiency (GHD) and peak GH levels <5 ng/mL cannot be overemphasized, according to a study published in Growth Hormone...

Suboptimal adherence to daily growth hormone treatment increases with treatment duration, and risk of discontinuation is associated with age, female gender, Black or Hispanic race/ethnicity, and obesity, according to a study...

There is a need to recognize growth hormone insensitivity (GHI) as a spectrum of clinical entities in undiagnosed short stature patients, according to a paper published in The Journal of Clinical Endocrinology and Metabolism....